McKenna 10 Year or Nicholson Reserve | Which Was Previously Bottled & Distilled by Pappy Van Winkle? Buy CaskCartel.com

www.CaskCartel.com

Order Online | Get Delivered | Christmas Gifts | Dad Gifts | Holiday Gifts”

— CaskCartel.com

US, December 8, 2019 /EINPresswire.com/ — Named the “Best in Show Whiskey” at San Francisco World Spirits Competition 2019, Henry McKenna 10 Year Single Barrel Bourbon needs no introduction. The extra-aged Bottled in Bond (BiB) single barrel bourbon became so popular after the last year’s competition, that’s now sold-out almost everywhere nationwide.

However, fine bourbon enthusiasts who cannot find Henry McKenna Single Barrel due to its allocated status look no further! David Nicholson Reserve Bourbon stands out as being the next best thing. In fact, the bourbon is seen as a hype-free, lower-cost alternative with plenty of current availability.

Until recently, most of David Nicholson Reserve has been sold in Missouri and Illinois. Now that Cask Cartel has brought it online thru its marketplace which makes it more appealing for fine-drink lovers from other states who can now finally grab a bottle of this amazing highly allocated bourbon.

In 2017 David Nicholson Reserve bourbon was also been showered in gold by winning the highest accolades with double gold medals in the San Francisco World Spirits Competition. Additionally, it also received the title of the “Best Straight Bourbon. The quality and value of this extra-aged “ryed” bourbon is peerless, making it an obvious choice.

ORIGINS

David Nicholson has humble origins and only hard work and passion made the brand gain popularity. This passion and continuous search for perfection has been crystallized in every drop of the precious liquid. The brands can trace its origins in the first half of the 19th century.
Named after it’s inventor, a St. Louis store owner who created the famous “43” bourbon recipe and sold it in 1843. Soon after that, Julian "Pappy" Van Winkle begins distilling and bottling the bourbon. David Nicholson whiskey remained in the Van Winkle family till 2000 when Luxco purchased it. Nonetheless, for almost 2 centuries, the recipe has been passed generation after generation and it has remained unaltered.

TASTING PROFILE:

David Nicholson Reserve Bourbon is a high-rye mashbill, bottled at 100-proof and with a perfect balance of sweet and spicy flavors.

-Aspect: Solid amber with glimmers of candy corn orange and barely-visible cloudiness.
-Nose: Vanilla, honey with toasted, oaky spice
-Palate: Smooth, spicy, sweet honey and just a hint of chocolate
-Finish: Toasty, full-bodied, with a nice long finish

Purchase it here!

About Lux Row Distillers

Luxco’s drive to innovate has quickly allowed them to become one of the top USA-based independent producers of alcohol beverage products. They produce and market a wide array of products across all categories. With over 18,000 square feet, 6 barrel warehouses at capacity and a 43-foot custom copper still, Lux Row Distillers is capable of producing 3 million gallons of spirit per year. When fully complete, they will process 50 thousand barrels of whiskey annually.

About Cask Cartel

Cask Cartel was founded in 2014 and brought online in 2018. It is a company that comprises a team with over 4 decades of experience in the alcohol beverage industry. Cask Cartel has extensive relationships with Producers and Brands across the US and the rest of the world that brings its customers first access to limited productions and allocated items. They are an E-Premise Marketplace that’s transforming the way premium spirits are shopped, sold and fulfilled online by combining the widest range selection of premium spirit beverages available.

Patrick Mitchel
Cask Cartel
+1 888-548-0333
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Biogenum Announces Favorable Safety Profile for Tau NonTangles™ in a Phase 1/2 Clinical Trial in Patients with Alzheimer

Tau NonTangles™ – small molecule for Alzheimer’s disease treatment is associated with clinical signs consistent with improvements in motor symptoms.

BUSAN, YEONGNAM, SOUTH KOREA, December 8, 2019 /EINPresswire.com/ — Biogenum (ISIN: KR7013369996), a clinical stage biopharmaceutical company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced topline results from the company’s Phase 1/2 clinical study evaluating Tau NonTangles™ – small molecule for Alzheimer’s Disease treatment, its potent and selective phosphodiesterase inhibitor, in patients with mild-to-moderate Alzheimer’s disease maintained on stable medication (e.g., dopamine replacement therapies). The results will be presented at the 2020 Neurological Committee Annual Meeting being held in Singapore.

The primary objective of this Phase 1/2, randomized, double-blind, placebo-controlled, multiple ascending dose cohort study was to evaluate the safety and tolerability of Tau NonTangles™ – small molecule for Alzheimer’s disease treatment and to explore the potential for Tau NonTangles™ to treat both motor and non-motor symptoms associated with AD. Topline results demonstrate Tau NonTangles™ was generally well-tolerated with a favorable safety profile and clinical signs consistent with improvements in motor symptoms and dyskinesias. The trial was conducted at the Center for Neurodegenerative Medical Research Unit.

“In this trial, once-daily Tau NonTangles™ for 7 days was shown to be safe and generally well tolerated across a broad range of doses from 1 mg to 80 mg in subjects currently maintained on dopamine replacement therapy,” commented Executive Vice President and Chief R&D Officer, Shin Hye-sung.

“Improvement in motor symptoms and reduction in motor complications were noted with Tau NonTangles™ treatment,” said Dr. Soung Myung-hee, Principal Investigator at the Center for Neurodegenerative Medical Research Unit, where the trial was conducted. “Several subjects with profound motor impairments improved dramatically while taking Tau NonTangles™ – small molecule for Alzheimer’s disease treatment, only to have these symptoms re-emerge after cessation of Tau NonTangles™ treatment.”

AboutTau NonTangles™ – Small molecule for Alzheimer’s disease treatment

The Tau NonTangles™ program discovers small molecules that are designed to inhibit the aggregation and seeding process of misfolded proteins and promote the disaggregation of already formed protein aggregates. Preclinical studies suggest reduction of pathological Tau aggregates leading to memory improvement.

About Biogenum
Biogenum is a privately held biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Alzheimer's disease, ALS and others. The quality, simplicity and sensitivity of its products brings precision medicine within reach. Composed of proprietary chemistry and software, Biogenum delivers powerful answers using broadly installed instrument platforms. The company’s leadership team has decades of experience in drug discovery, translational strategy, corporate development and commercialization. Collectively, we have been instrumental in researching more than 10 drugs to be delivered in the market.

Alice Lum
Biogenum
+82 1855552863
email us here


Source: EIN Presswire

Biogenum Appoints Hahn Se-young as Executive Vice President, Chief Commercial Officer

Hahn Se-young has a Bachelor of Management Economics and Business Administration degree from an MBA College in Tokyo

BUSAN, YEONGNAM, SOUTH KOREA, December 8, 2019 /EINPresswire.com/ — Biogenum (ISIN: KR7013369996), a clinical stage biopharmaceutical company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, is pleased to announce the appointment of Hahn Se-young as Executive Vice President, Chief Commercial Officer. Mr. Se-young has over 30 years of biopharmaceutical industry experience with a strong track record of building high-performing commercial teams and successfully executing numerous product launches across a range of therapeutic areas including specialty and primary care businesses.

Mr. Hahn Se-young joins Biogenum from a top research laboratory where he was initially recruited as Vice President, to build and establish a new neurodegenerative research business unit, and launch the laboratory’s first ever neurodegenerative medicines. In his most recent role as Vice President with leadership of nephrology, inflammation, and brain health, he was responsible for conceiving therapeutic area strategies, developing drug platforms for global launches and directing commercial assessments for external business development opportunities.

Prior to the laboratory, Mr. Se-young spent 15 years at a top pharmaceutical company and held senior commercial roles in neuroscience for the Southeast Asia Pacific Region, cardiovascular and diabetes. During his tenure at the helm of sales and marketing for the neuroscience business unit he delivered strong growth of the antipsychotic division. He also held the position of Vice President Commercialization for neuroscience where he established a new worldwide disease area strategy and directed the commercialization of neuroscience pipeline assets.

“Hahn is a proven leader with broad experience developing and implementing commercial strategies for early and late-stage assets within neuroscience and cardiovascular therapeutic fields. We believe his expertise further strengthens and complements our growing organization as we prepare for the commercialization of BGM-27 immunotherapy targeting pTau and further advance our pipeline,” said Executive Vice President and Chief Medical Officer, Yoon Hae-joo.

"I am very excited to join the leadership team at Biogenum and look forward to leading the commercial organization as we advance the launch preparations for BGM-27 immunotherapy targeting pTau as well as developing commercial strategies for the Company’s pipeline,” said Mr. Se-young.

About Biogenum
Biogenum is a privately held biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, ALS and others. The quality, simplicity and sensitivity of its products brings precision medicine within reach. Composed of proprietary chemistry and software, Biogenum delivers powerful answers using broadly installed instrument platforms. The company’s leadership team has decades of experience in drug discovery, translational strategy, corporate development and commercialization. Collectively, we have been instrumental in researching more than 10 drugs to be delivered in the market.

Alice Lum
Biogenum
+82 1855552863
email us here


Source: EIN Presswire

Community Health 1st ER Gives Back by Providing 400 Free Turkeys to Community

Community Health 1st ER - CH1ER Logo

CH1ER Turkey Tour Event - Community Health 1st ER

CH1ER Turkey Tour Event

The goal of the stand-alone ER is to engage business through goodwill and positive intentions.

As an organization, we are going to continue to engage business with goodwill and positive intentions.”

— Jay Mackey

DEER PARK, TX, UNITED STATES, December 6, 2019 /EINPresswire.com/ — Community Health 1st ER is pleased to announce it has continued to give back to its community by providing 400 free Thanksgiving turkeys on November 25th, 2019.

Community Health 1st ER is a brand new, 9000 sq. ft. state-of-the-art facility designed to deliver the most effective and efficient emergency care in a comfortable and stress-free environment – 24/7. The stand-alone ER facility provides patients with 30% more exam rooms than typical freestanding ER facilities and employs board-certified ER doctors and registered nurses.

On November 25th, 2019, CH1ER served the community in a different way with their Turkey Tour free Thanksgiving turkey giveaway. During this event, the staff at Community Health 1st ER gave away 400 free turkeys to individuals and families in need who visited the facility.

“As an organization, we are going to continue to engage business with goodwill and positive intentions,” says Jay Mackey, founder and CEO of Community Health 1st ER. “We are thankful to have the opportunity to give back to the communities that have supported us and enabled us to grow to where we are today.”

“CH1ER was built on cultivating meaningful relationships with the people,” Mackey continues. “On this Thanksgiving holiday, we wanted to show our appreciation by donating to those in need. The event was a tremendous success and we look forward to continued events such as this into the future.”

For more information about Community Health 1st stand alone ER, please visit https://www.ch1er.com.

About the Company

Community Health 1st ER implements core values including transparency, commitment, and compassion. In their facility, all team members work tirelessly to earn client trust, improve health, and restore quality of life in a timely manner.

The stand-alone ER facility is rapidly becoming one of the top rated urgent care facilities in Deer Park, Texas.

Randy Haddox
Community Health 1st ER
+1 346-954-6007
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Ultra-Rare Macallan 1950 Exceptional Cask 67 Year Old Scotch Whisky Available At CaskCartel.com

www.CaskCartel.com

Order Online | Get Delivered | Christmas Gifts | Dad Gifts | Holiday Gifts”

— CaskCartel.com

US, December 6, 2019 /EINPresswire.com/ — Macallan 1950 Exceptional Cask 67 Year Old Whisky is an incredibly rare vintage Macallan with only 336 ever bottled worldwide. For a short period after its release in July 2019, this whiskey was only available from select luxury retailers in the UK. Now CaskCartel.com is excited to have acquired 1 ultra-rare limited edition Macallan 1950. Cask Cartel has extensive partners and relationships with producers, brands and licensed local retailers giving access to all of the limited, rare and ultra-rare Scotches, Bourbons, and Tequilas. All of this available right on your desktop, laptop or mobile phone! #StopSearching #StartSipping #StartGiving #CaskCartel

Cask Cartel is America’s largest online premium spirits marketplace. Through combined superior customer service and access to over 5,000 products CaskCartel works to bring limited edition, award-winning and world-sought bottles straight to your home. As Macallan 1950 is one of the world’s most exclusive bottles to date, this limited quantity bottle won’t be available for long.

The Macallan Exceptional Casks series takes its name from a number of single cask Macallans released during the 1990s. These bottles are often described as some of the greatest Macallans of all time. For someone who has everything, Macallan 1950 Exceptional Cask 67 Year Old Whisky is a true collectors dream. This Macallan is considered the pinnacle of this Exceptional Single Cask range line up. Macallan 1950 was distilled on the 9th November in 1950 and after maturing for over 67 years in a single American Oak first-fill Sherry, it has finally been released to the United States. Once you have your hands on this bottle, enjoy the aroma of Polished Antique oak, with delicate scents of peaches and vanilla. The taste presents intense tasting notes of antique oak and wood spice followed by a long finish filled with dry sweetness and peat.
Enjoy browsing the complete collection at CaskCartel.com. Using only licensed and reputable retail partners, Cask Cartel guarantees doorstep delivery of Macallan 1950 to complete this limited edition collection.

About Cask Cartel
Cask Cartel has become the greatest online marketplace for premium spirits. The company prides itself by operating with decades of customer service experience and a team of top tier individuals prized within the alcohol beverage industry. Cask Cartel has extensive partners and relationships with Producers, Brands and the Local Retailers which grant consumers online access to new arrivals, limited productions and allocated items. Their E-Premise Marketplace transforms the way premium spirits are shopped sold and fulfilled by combining a network of the largest range of liquor selections available online.

Patrick Mitchel
Cask Cartel
+1 888-548-0333
email us here


Source: EIN Presswire

Groom & Associates responds to the high demand for technology and engineering talent by changing their focus.

Groom and Associates

Canada’s leading recruitment firm Groom Associates now specializes in recruiting talent for specific sectors.

MONTREAL, TORONTO, QUEBEC, ONTARIO, CANADA, December 6, 2019 /EINPresswire.com/ — Previously known as Canada’s leading recruitment firms for a wide range of industries, Groom & Associates now specializes in recruiting talent for specific sectors.

“We now serve the IT and AI, Life Sciences, Engineering and Industrial, and Finance industries exclusively,” says Karen Groom, founder and CEO of Groom.

As Canadian cities are becoming important hubs for AI research, and as the country’s pharmaceutical market is predicted to grow to $25 billion by 2021 according to various reports, demand for tech and engineering specialists seems to be outpacing supply.

“Engineers, data scientists, and other IT professionals have a lot of choice when it comes to where they want to work. Biopharma and tech companies are popping up all over the country, and they all require highly skilled people,” explains Groom.

One notable challenge faced by employers in these industries is hiring specialists who possess both leadership and managerial experience.

“We work with clients seeking to fill roles that simply didn’t exist 10 or even 5 years ago, such as Blockchain Engineer or Data Scientist. It means that people with the hard skills for these emerging roles might have the talent, but not necessarily years of executive experience,” she says.

Canadian employers turn to Groom when looking to fill AI, IT, and engineering roles because many of the recruiters at Groom & Associates have education or work experience in the STEM fields themselves. They’re able to genuinely connect with candidates to ensure a sound understanding of what a candidate wants, and whether or not their skills and attitude suit the role in question – including managerial positions. According to Groom, employers must also promote their corporate culture and other variables in order to attract talent.

“It’s important that companies promise more than a competitive salary; they must offer interesting and challenging projects that will be meaningful to the people they seek to hire,” reveals Groom.

“We help companies better communicate their corporate culture and corporate social responsibility to candidates, because it's something that candidates today are interested in. It’s not that salary isn’t important, but people are keenly interested in how a company is seeking to improve society, where they’ll fit in, what the working atmosphere is like, and how dedicated to diversity a company is.”

The Groom team is comprised of hiring experts from a myriad of cultural backgrounds and languages, and proudly reports that diversity is their strength. They believe that diversity is important not only for attracting top candidates, but for better employee retention rates and company success as a whole.

“We’ve decided to serve the specific industries that we believe have enormous growth potential. Our clients are benefitting from our narrowed focus and from our team of recruiters with backgrounds in technology and science; not to mention our dedication to promoting diversity.”

Miriam Groom
Groom and Associates
+1 514-288-3222
email us here


Source: EIN Presswire

Regen Lab SA Featured on the Cover of Tissue Engineering USA and MDSAP Certification

Regen Lab on Tissue Engineering

Regen Lab on Tissue Engineering

Regen Lab SA Is the First Company in the PRP Field to Be Successfully Audited under the MDSAP

LE MONT-SUR-LAUSANNE, SWITZERLAND, December 6, 2019 /EINPresswire.com/ — Antoine Turzi, CEO of Regen Lab SA Switzerland, is delighted to announce that the work of Regen Lab’s research team has been selected for the cover of the November 2019 issue of the prestigious Tissue Engineering journal*.

Our work demonstrates that fibroblasts derived from human skin grow almost 10 times faster in medium supplemented with RegenPRP®/Cutecell® than with fetal bovine serum. Growth of the cells in RegenPRP did not affect the genomic stability of the cells.

In addition, Regen Lab becomes the first PRP-based company to be successfully audited under the Medical Device Single Audit Program (MDSAP). This is an important milestone for Regen Lab, as MDSAP is mandatory in Canada since January 1, 2019. Companies that are not MDSAP compliant can no longer commercialize in Canada. At the ICRS conference in October 2019, Dr Anz confirmed that the USA will make MDSAP mandatory in 2020. Other countries are expected to follow.

Regen Lab is proud of meeting the essential conditions for full Freedom to Operate by investing in R&D to create and develop innovative and effective products, with strong patent protection and results published in peer-reviewed journals, while ensuring full regulatory compliance with MDR745 in Europe and MDSAP globally.

*Autologous Platelet-Rich Plasma (CuteCell PRP) Safely Boosts In Vitro Human Fibroblast Expansion

_______________________________

RegenLab is a leading innovator of medical devices for the preparation of platelet rich plasma (PRP), which it markets under the well-recognized REGENLAB®, REGENKIT® and CELLULAR MATRIX brands.
RegenLab remains committed to providing pyrogen-free devices of the highest safety & efficacy, as well as protecting physicians through enforcement of its intellectual property rights.

Additional information about RegenLab and its patents can be found at Regen Lab patents.

_______________________________

Regen Lab SA
En Budron B2
CH – 1052 Le Mont-Sur-Lausanne
Switzerland

Regen Lab
Contact Information
+41 21 864 01 11
email us here


Source: EIN Presswire

LSI awarded SAP contract at Arrowhead Regional Medical Center

Digital Enterprise Cloud

Intelligent Enterprises for Healthcare

SAN BERNARDINO, CALIFORNIA, USA, December 6, 2019 /EINPresswire.com/ — LSI announced today that it will partner with the Arrowhead Regional Medical Center (ARMC) to implement SAP Financials & Logistics.

“We are looking forward to the increased efficiencies that this partnership will provide,” said ARMC Chief Financial Officer, Arvind Oswal.

LSI’s expertise in digitalizing every aspect of our client’s value chain aims to help healthcare stakeholders provide the best value to their customers at an affordable cost. We create the foundation and gateways to connect the digital healthcare network to core solutions for patient engagement, care delivery, care collaboration, clinical analytics, and personalized medicine.

“The County of San Bernardino continues to extend the power & flexibility of SAP to gain efficiencies throughout its various business units.”, explained Steve Roach, CEO and President at LSI. “We are privileged to assist the Arrowhead Regional Medical Center with the digitalization of its business processes and are excited to welcome them to SAP’s Healthcare ecosystem.”

About LSI
LSI was founded in 1998 with a mission to transform government, national security, healthcare and education via the adoption of best-in-class business practices and digitalization. Fast forward to today and LSI leverages secure and cutting-edge technologies engineered by SAP to create the Intelligent Public Enterprise for Federal, State, Local Government, Education, Utility and Healthcare organizations.

About Arrowhead Regional Medical Center
Arrowhead Regional Medical Center (ARMC) is a 456-bed university-affiliated teaching hospital licensed by the State of California Department of Public Health and operated by the County of San Bernardino. The hospital, located on a 70-acre campus in Colton, California, operates a regional burn center, a primary stroke center, a level II trauma center, a behavioral health center located on the hospital campus, four primary care centers including three family health centers, and provides more than 40 outpatient specialty care services.

Caroline Silva
LSI
+1 978-732-8215
email us here


Source: EIN Presswire

Certified EMDR Therapist Micki Halloran to be Featured on CUTV News Radio

SANTA FE, NEW MEXICO, UNITED STATES, December 6, 2019 /EINPresswire.com/ — At some point in our lives, most of us will suffer from distressing or traumatic life events that may leave us emotionally scarred. We become broken, deeply distressed and without joy. This is because when bad things happen to us memories can linger and haunt us deeply. If left unhealed they will only compound over time. A part of us may even feel trapped, reliving the past. Trying to cope by self-medicating with drugs or alcohol only worsens our health and overall emotional well-being. A ground-breaking therapeutic approach EMDR (Eye movement Desensitization and Reprocessing), is proving that treating and healing trauma that once took years to be effective is now absolutely possible. EMDR is the most researched trauma therapy utilized today. Millions of people have been treated successfully over the past 25 years with EMDR. Over 100,000 therapists worldwide use EMDR therapy.

Micki Halloran MA LPC, LPCC is an exceptionally skilled Psychotherapist in private practice for over thirty-five years with a specialty in helping people heal from trauma and early and recent adverse life events. She is an EMDR Certified Therapist, Consultant and EMDR Institute Facilitator.

“Since I started utilizing EMDR with my clients in 2002, I have been astonished time and again witnessing individuals experience the benefits of healing that would otherwise have taken years to make a difference.”

Brain research shows our minds can heal from psychological traumas just as the body can heal from physical trauma. With EMDR therapy we see debilitating wounds not just heal but transform. Our amazing brain naturally wants to move toward healing but if the inner system is blocked or thrown out of balance by the impact of a disturbing event, the emotional wound can fester and cause more intense suffering. Once the block is removed, healing occurs. With EMDR emotional, physical and psychological blocks can be permanently removed.

Developed in 1987 by Francine Shapiro PhD, EMDR therapy uses the individual’s own rapid, rhythmic eye movements. EMDR is a phased, fixated method to healing trauma and other adverse life events by connecting the client to images and emotions related to the particular original experience encouraging the natural healing powers of the brain to move toward dramatic recovery.

Micki is also a certified Havening® practitioner. Havening®, originally known as Delta Wave Techniques is a deceptively simple technique which can remove the results of trauma or phobias in as little as one session. Therapists, nurses, coaches, midwives and doctors and more can receive Havening® training. Using distraction and applied or self- touch, usually on upper arms, face or hands, erases the encoding of the a particular trauma in the brain. The landscape of the brain is altered so that the thought of an event and its emotional impact are delinked permanently.

Micki’s objective is to see Havening® and EMDR become more prominently recognized and utilized by therapists worldwide. As a facilitator for these life-changing therapies she witnesses people’s lives change in positive ways again and again.

“There is a spiritual component in my work helping people find their own profound wisdom and tap into their own core strength and inner peace. No matter what hardships we have to endure there is promise and hope when we are open to healing,” says Micki. “Believe there is hope and always truly follow your heart and you can enter into a more joyful, productive and healthier life.”

CUTV News Radio will feature Micki Halloran in an interview with Jim Masters on Tuesday December 6th at 1 p.m. EST

Listen to the show on BlogTalkRadio

If you have any questions for our guest please call (347) 996-3389

Written By: Beatrice Maria Centeno

Lou Ceparano
CUTV News
(631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Cheryl Guttenberg of Trapped Emotion Healing to be Featured on CUTV News Radio

NORTHRIDGE, CALIFORNIA, UNITED STATES, December 6, 2019 /EINPresswire.com/ — Each of us has trapped emotions in our body. These emotions can arise from physical pain, illness, relationships, and we accumulate these trapped emotions from the time we're in the womb throughout our entire life.

If we want more abundance in our life, we must release our trapped emotions. Once we release these trapped emotions, we are open to receive good.

Cheryl Guttenberg is a certified Emotion Code Practitioner and founder of Trapped Emotion Healing.

As a healer, Cheryl helps her clients overcome physical and emotional issues while attracting abundance in the areas that bring them the most joy into their lives.

“I help people in ways I never thought possible,” says Cheryl, “and I'm very grateful to the universe for guiding me along this path.”

After working in the corporate world as a Human Resources Leader for 20 years, Cheryl decided to take her skills to a more personal level. In 2014, she became a Certified and Licensed Heal Your Life ® Coach, based on the works of Louise Hay. More recently, she became a Certified Emotion Code Practitioner.

“I was always in a role of helping people. I've always coached people,” recalls Cheryl. “When I discovered the Emotion Code, I remember thinking, ‘I don't know what this is about,’ but I got the distinct message from spirit that I needed to do this, and I did it.”

Cheryl says her clients are amazed by the immediate results they experience following their Emotion Code sessions.

“I work with my clients to connect with the subconscious mind,” says Cheryl. “The subconscious knows when we trapped an emotion, how old we were, how deep it is.

Though Cheryl is a healer, she says she is not really the one doing the healing. She is merely a conduit, and spirit is working through her. She just knows the right questions to ask.

“All of us are healers. Not everyone is open to that or is aware of it. The way the universe works is the people who are really open to this are the ones that find you.”

CUTV News Radio will feature Cheryl Guttenberg in an interview with Jim Masters on December 10th at 12pm EST

Listen to the show on BlogTalkRadio

If you have any questions for our guest, please call (347) 996-3389

For more information, visit www.trappedemotionhealing.com

Lou Ceparano
CUTV News
(631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire